4F1S

Crystal structure of human PI3K-gamma in complex with a pyridyl-triazine-sulfonamide inhibitor

4F1S の概要

• エントリーDOI: 10.2210/pdb4f1s/pdb
• 関連するPDBエントリー: 4DK5
• 分子名称: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, SULFATE ION, N-(5-{[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(tetrahydro-2H-pyran-4-yl)pyridin-2-yl]amino}-2-chloropyridin-3-yl)methanesulfonamide, ... (4 entities in total)
• 機能のキーワード: phosphotransferase, lipid kinase, p85, transferase-inhibitor complex, transferase/inhibitor
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Cytoplasm: P48736
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 110891.40

構造登録者

Whittington, D.A.,Tang, J.,Yakowec, P. (登録日: 2012-05-07, 公開日: 2012-08-08, 最終更新日: 2024-02-28)

• 主引用文献: Wurz, R.P.,Liu, L.,Yang, K.,Nishimura, N.,Bo, Y.,Pettus, L.H.,Caenepeel, S.,Freeman, D.J.,McCarter, J.D.,Mullady, E.L.,Miguel, T.S.,Wang, L.,Zhang, N.,Andrews, K.L.,Whittington, D.A.,Jiang, J.,Subramanian, R.,Hughes, P.E.,Norman, M.H.; Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold.; Bioorg.Med.Chem.Lett., 22:5714-5720, 2012; PubMed: 22832322; DOI: 10.1016/j.bmcl.2012.06.078

実験手法

X-RAY DIFFRACTION (3 Å)